Cybin (HELP) Operating Income (2020 - 2021)

Cybin (HELP) posted Operating Income of $145656.7 for Q1 2021, up 100.09% on a QoQ basis from -$162.1 million in Q4 2020.

Cybin (HELP) Operating Income (2020 - 2021) Analysis & Trends

Cybin's Operating Income history runs 2 years deep, the most recent figure standing at $145656.7 for Q1 2021.

Quarterly Operating Income changed N/A year-over-year to $145656.7 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was -$17.8 million (changed N/A YoY) and the FY2023 annual result came in at -$18.8 million, changed N/A from the prior year.
Operating Income was $145656.7 for Q1 2021 at Cybin, up from -$162.1 million in the prior quarter.
Across five years, Operating Income topped out at $144.2 million in Q2 2020 and bottomed at -$162.1 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Op. Inc (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-27.75 Mn
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-15.76 Mn
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	249.90 Mn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	1.14 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	642.90 Mn
7	Belite Bio	61.40 Bn	61.40 Bn	-	-32.68 Mn
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	394.00 Mn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-445.22 Mn
10	Cybin	262.76 Mn	262.76 Mn	-	-

Download Data